A prospective trial of intradetrusor onabotulinumtoxinA injections assessing long-term outcomes and adherence to treatment in patients with refractory neurogenic detrusor overactivity.
Phase of Trial: Phase IV
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 30 Jun 2016 New trial record